Publications of Marcelo Páez-Pereda
All genres
Journal Article (48)
2020
Journal Article
182 (1), pp. R1 - R13 (2020)
Translational research in pituitary tumours. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2019
Journal Article
: Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter. NEUROENDOCRINOLOGY 109 (4), pp. 362 - 373 (2019)
Journal Article
10, 676 (2019)
Sleep Deprivation Alters the Pituitary Stress Transcriptome in Male and Female Mice. FRONTIERS IN ENDOCRINOLOGY 2017
Journal Article
: Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function. NATURE COMMUNICATIONS 8, 1725 (2017)
Journal Article
26 (1), pp. 75 - 84 (2017)
Currently used and investigational drugs for Cushing's disease. EXPERT OPINION ON INVESTIGATIONAL DRUGS 2016
Journal Article
: Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function. PLOS ONE 11 (3), e0151862 (2016)
Journal Article
: Hypothalamic leptin action is mediated by histone deacetylase 5. NATURE COMMUNICATIONS 7, 10782 (2016)
2015
Journal Article
290 (33), p. 20627 - 20627 (2015)
Function and Structure of the RWD Domain. JOURNAL OF BIOLOGICAL CHEMISTRY
Journal Article
21 (3), pp. 276 - 280 (2015)
A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. NATURE MEDICINE 2013
Journal Article
33 (11), pp. 2116 - 2127 (2013)
RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity. MOLECULAR AND CELLULAR BIOLOGY
Journal Article
27 (4), pp. 1561 - 1571 (2013)
Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. FASEB JOURNAL 2012
Journal Article
7 (8), pp. 1351 - 1359 (2012)
The Prospect of FKBP51 as a Drug Target. ChemMedChem 2011
Journal Article
20 (4), pp. 519 - 535 (2011)
Corticotropin releasing factor receptor antagonists for major depressive disorder. Expert Opinion on Investigational Drugs 2010
Journal Article
326 (1-2), pp. 85 - 88 (2010)
Pituitary tumors: Cell type-specific roles for BMP-4. Molecular and Cellular Endocrinology
Journal Article
70 (2), pp. 666 - 674 (2010)
The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research 2009
Journal Article
117 (10), p. 656 - 656 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Experimental and Clinical Endocrinology & Diabetes
Journal Article
117 (10), p. 656 - 656 (2009)
Activation of NOD and TLR4 innate immune receptors in tumoral pituitary cells and their effects on downstream targets. Experimental and Clinical Endocrinology & Diabetes
Journal Article
203 (1), pp. 111 - 122 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Journal of Endocrinology
Journal Article
23 (7), pp. 1102 - 1114 (2009)
Molecular Interaction of BMP-4, TGF-beta, and Estrogens in Lactotrophs: Impact on the PRL Promoter. Molecular Endocrinology
Journal Article
10 (2 Sp. Iss. SI), pp. 103 - 109 (2009)
Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas. Reviews in Endocrine & Metabolic Disorders